SSA
ICU icon

Schonfeld Strategic Advisors’s SeaStar Medical ICU Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ICU Stock Details ICU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43
Closed -$109K – 2788
2022
Q3 		$109K Hold
43
– – ﹤0.01% 2524
2022
Q2 		$108K Hold
43
– – ﹤0.01% 2113
2022
Q1 		$108K Sell
43
-64
-60% -$161K ﹤0.01% 2209
2021
Q4 		$268K Buy
107
+14
+15% +$35K ﹤0.01% 1561
2021
Q3 		$233K Buy
+93
New +$230K ﹤0.01% 1687

Other funds holding ICU

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
SWA
SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's ICU Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 43 shares — an estimated $109K sold.

Schonfeld Strategic Advisors first reported a position in ICU in Q3 2021 and held it in 5 quarters. The position peaked at $268K in Q4 2021. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 43 SeaStar Medical shares in Q4 2022, an estimated $109K.
  • Schonfeld Strategic Advisors first reported a position in SeaStar Medical in Q3 2021 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's SeaStar Medical position peaked at $268K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.